AGP Executive Report
Last update: 12 hours agoDrugmakers: GSK beat third-quarter expectations as sales of newer medicines grew 5% to £8.89 billion; it kept its annual outlook, while forecasting faster growth in research spending. Flu Alert: Karachi hospitals say flu cases have nearly doubled in recent weeks. Doctors urge vaccination and masks in crowded places, especially for children, older people and people with HIV. Rare-Disease Pipeline: Nxera Pharma secured Asia-Pacific rights to investigational Fabry disease drug lucerastat and will join its global Phase 3 program, which could support a filing as early as 2029. Medicine Access: KEMSA handed over a refurbished medicine store at Kenya’s Port Reitz Hospital, aiming to protect supplies and improve inventory management for a community of more than 300,000. Remote Care: A proposed Medicare rule could cut payments for remote monitoring services run through outside technology firms, potentially limiting access for rural patients who rely on home devices and coaching.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
